drugset / Trial / NCT01127165

Low and High Dose Zonisamide in Children as Monotherapy

NCT01127165

Phase 4 Completed 125 enrolled Eisai Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to confirm the adjustment dosage of zonisamide as monotherapy in children with epilepsy.

Timeline

Start
2006-03
Primary completion
2009-03
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified

Indications